Greenwich LifeSciences, Inc. (GLSI)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Greenwich LifeSciences, Inc. (GLSI)
Company Performance

Current Price

as of Oct 18, 2024

$13.53

P/E Ratio

N/A

Market Cap

$177.85M

Description

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Metrics

Overview

  • HQStafford, TX
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerGLSI
  • Price$13.53-4.72%

Trading Information

  • Market Cap$177.85M
  • Float45.07%
  • Average Daily Volume (1m)26,903
  • Average Daily Volume (3m)31,845
  • EPS-$0.79

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$2.61M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$2.66M
  • EV$215.55M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B30.09
Documents